You searched for FDA - Page 5 of 35

Representative Image. Depressed Man. Photo Source: HolgersFotografie (Pixabay)

Health

FDA Approves Spravato Nasal Spray as Standalone Treatment for Depression

The FDA has approved a new way to use Spravato, a nasal spray that helps people with severe depression. Now doctors can prescribe it by itself, instead of requiring patients to take

Tejal Somvanshi

January 24, 2025

Health

FDA Approves ZYN Nicotine Pouches as Safer Alternative but Sparks Concerns Over Teen Use and Flavored Optionsv

The FDA has approved small nicotine pouches called ZYN. These pouches are placed between the lip and gum, similar to traditional anti-smoking methods like nicotine patches or gum. “There is no safe

Tejal Somvanshi

January 20, 2025

Health·News·USA

FDA Bans Red Dye No. 3: Thousands of Foods and Drinks to Change by 2027

The FDA’s ban on Red Dye No. 3 will remove a common food coloring from thousands of U.S. products. The synthetic dye, chemically known as erythrosine and made from petroleum, gives foods

Karmactive Staff

January 17, 2025

Prepared Monkfish Liver (Ankimobo) Photo Source :Mutual trading

Health

Monkfish Liver Recalled in Five States for Undeclared Milk Allergen, FDA Warns Allergy Risks.

New York Mutual Trading Co. has recalled its Prepared Monkfish Liver from stores and restaurants across five states after discovering it contains undeclared milk ingredients. For someone with milk allergies, it could

Tejal Somvanshi

January 17, 2025

Representative Image. Grayscale Photo of Eggs on a Tray. Photo Source: Renato K. (Pexels)

Health·News·USA

FDA Elevates Costco Egg Recall to Highest Risk Level Over Salmonella Concerns

The U.S. Food and Drug Administration (FDA) has upgraded the Costco egg recall to Class I – its highest risk classification. The recall, initiated by Handsome Brook Farms on November 27, 2024,

Tejal Somvanshi

December 25, 2024

Representative Image. Woman Sleeping. Photo Source: Ivan Obeleninov (Pexels)

Health·News·USA

FDA Approves Zepbound: First Sleep Apnea Drug Reduces Breathing Events by 25/hour, 18% Weight Loss

The U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide), marking the first medication authorized for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The approval comes

Tejal Somvanshi

December 24, 2024

Representative Image. A Person Holding his Belly Fat. Photo Source: Towfiqu barbhuiya (Pexels)

Health

FDA Ends Tirzepatide Shortage, Orders Compounded Versions Phased Out by March 2024

The Food and Drug Administration (FDA) confirmed Thursday that Eli Lilly’s tirzepatide-based medications, Zepbound and Mounjaro, are no longer in shortage. This decision requires compounding pharmacies to cease production of alternative versions

Tejal Somvanshi

December 21, 2024

Representative Image. A dog having the medical check-up. Photo Source: Gustavo Fring (Pexels)

Health·News·USA

FDA Warns: Librela Linked to 3,600+ Adverse Reactions, Including Seizures and Deaths in Dogs

The Food and Drug Administration’s Center for Veterinary Medicine has issued an urgent warning about Librela, a widely-used injectable medication for dogs with osteoarthritis, following reports of severe adverse effects including deaths.

Tejal Somvanshi

December 21, 2024

A confident man in a suit delivers a speech at a podium, with a bright blue background.

Health·News·USA

RFK Jr.’s Lawyer Petitioned FDA to Revoke Polio Vaccine Approval

Aaron Siri, a lawyer helping Robert F. Kennedy Jr., has filed petitions seeking to revoke FDA approval of the polio vaccine and suspend distribution of 13 other vaccines. This development comes as

Tejal Somvanshi

December 18, 2024

Health·USA

FDA Recalls 7,107 Duloxetine Bottles Due to Cancer-Linked N-Nitroso Contamination Risk

Rising Pharmaceuticals has initiated a nationwide recall of 7,107 bottles of duloxetine after discovering contamination with N-nitroso-duloxetine, a chemical compound linked to cancer risks. The recall, classified as Class II by the

Tejal Somvanshi

December 13, 2024